Australian (ACL) is held by 7 ASX ETFs. Over the last 3 months it rose 31.1%: on $10,000, +$3108. We explain 3 big moves in that time.
About ACL
- SectorHealth Care
- IndustryHealth Care Equipment & Services
- Size$522.3m
- Held by7 ETFs
- Big moves3 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +5.0%peak +7.1%9 Oct 2026· Stake Change
Citigroup filed a substantial shareholder notice disclosing a 5.12% voting stake in Australian Clinical Labs, signalling new institutional buying interest.
- +14.9%peak +21.7%17 Aug 2026· Earnings Beat
Australian Clinical Labs shares surged after analyst/media coverage highlighting improving margins and an earnings growth outlook despite softer revenue, attracting renewed buyer interest.
- +6.2%16 Jul 2026· Unknown
ACL.AX rose sharply with no clear trigger, as the modest 0.5% gain in the broader healthcare sector index is far too small to explain a 5.5% move, leaving the cause unknown.
Held by 7 ETFs
Of every $10,000 in each fund, how much is in ACL today.
- MVSVanEck Small Companies Masters ETF$1711.71%
- SSOSTATE STREET SPDR S&P/ASX SMALL ORDINARIES ETF$180.18%
- ISOiShares S&P/ASX Small Ordinaries ETF$180.18%
- QOZBetaShares FTSE RAFI Australia 200 ETF$7.130.07%
- VETHVanguard Ethically Conscious Australian Shares ETF$2.520.03%
- A300Global X Australia 300 ETF$2.040.02%
- VASVanguard Australian Shares Index ETF$1.780.02%
Why did ACL rise 5.0% on 9 Oct 2026?
Australian
Citigroup filed a substantial shareholder notice disclosing a 5.12% voting stake in Australian Clinical Labs, signalling new institutional buying interest.
The ASX substantial holder filing (released at 06:41 UTC, shortly after detection) and the contemporaneous Kalkine news article both confirm Citigroup crossed the 5% disclosure threshold in ACL. This type of institutional accumulation is a well-known catalyst for price spikes as the market interprets it as a signal of buying interest or potential strategic intent. The sector index moved only 0.73% versus ACL's 5%+ move, ruling out sector rotation as the driver, and there were no earnings, guidance, or M&A announcements to explain the magnitude.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
Company announcements
News coverage
Sector / macro signals
What it did to the 7 ETFs holding ACL
On $10,000 in each fund, at the weight it holds today